diethylstilbestrol has been researched along with Disease Exacerbation in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (28.00) | 18.2507 |
| 2000's | 13 (52.00) | 29.6817 |
| 2010's | 5 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Attard, G; Bianchini, D; de Bono, JS; Dearnaley, D; Ferraldeschi, R; Lorente, D; Mukherji, D; Omlin, A; Parker, C; Pezaro, CJ; Sandhu, S; Van As, N; Zaidi, S | 1 |
| Cherny, N; Gabizon, A; Gips, M; Grenader, T; Plotkin, Y | 1 |
| Chahal, R; Cross, WR; Prescott, S; Sundaram, SK; Tan, K; Thygesen, H; Turo, R | 1 |
| Chen, J; Crum, CP; Lu, ZH; Zhou, WX | 1 |
| Beard, R; McFaul, S; Mills, R; Mithal, N; O'Brien, N; Oliver, T; Powles, T; Protheroe, A; Sarker, SJ; Shamash, J; Tranter, N; Wilson, P | 1 |
| Dearnaley, D; Gunapala, R; Horwich, A; Huddart, R; Parker, C; Shahidi, M; Thomas, K; Wilkins, A | 1 |
| Hayes, DF | 1 |
| Bok, R; Bubley, GJ; Derynck, MK; DiPaola, RS; Jones, G; Kantoff, PW; Oh, WK; Rini, BI; Rosen, RT; Small, EJ; Smith, MR; Weinberg, V | 1 |
| Pitts, WR | 2 |
| Walsh, PC | 1 |
| Garcia, JA; Small, EJ; Weinberg, V | 1 |
| Belayew, A; Debauve, G; Gerbaux, C; Journé, F; Laurent, G; Leo, O; Nonclercq, D; Ribaucour, F; Toubeau, G; Wiedig, M | 1 |
| Nomura, K; Wakisaka, M | 1 |
| Bertelli, G; Bruzzi, P; Del Mastro, L; Garrone, O; Guelfi, M; Pastorino, S; Rosso, R; Sertoli, MR; Venturini, M | 1 |
| Hirano, S; Kakinuma, H; Kato, T; Miura, K; Sasaki, R; Sasaki, S; Sato, K | 1 |
| Bishop, MC | 1 |
| Chao, D; Harland, SJ | 1 |
| Hartmann, LC; Ingle, JN; Loprinzi, CL; Peethambaram, PP; Suman, VJ | 1 |
| Kawada, Y; Kuriyama, M; Ohshima, S; Ono, Y; Shimizu, H; Takahashi, Y | 1 |
| Fujikawa, K; Itoh, T; Miyakawa, M; Nishio, Y; Sasaki, M | 1 |
| Albertsen, PC; Aronson, N; Bennett, CL; Hasselblad, V; Samson, DJ; Seidenfeld, J; Wilt, TJ | 1 |
| Bayoumi, AM; Brown, AD; Garber, AM | 1 |
| Chatta, GS; Coleman, D; Crawford, ED; Eisenberger, MA; Fisher, E; Hussain, MH; Kucuk, O; Lowe, BA; Moinpour, CM; Sartor, AO | 1 |
| Furuya, Y; Fuse, H; Nagakawa, O; Nozaki, T | 1 |
1 review(s) available for diethylstilbestrol and Disease Exacerbation
| Article | Year |
|---|---|
Single-therapy androgen suppression in men with advanced prostate cancer: a systematic review and meta-analysis.
Topics: Androgen Antagonists; Antineoplastic Agents, Hormonal; Clinical Trials, Phase II as Topic; Diethylstilbestrol; Disease Progression; Disease-Free Survival; Gonadotropin-Releasing Hormone; Humans; Male; Orchiectomy; Prospective Studies; Prostatic Neoplasms; Quality of Life; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Survival Analysis | 2000 |
9 trial(s) available for diethylstilbestrol and Disease Exacerbation
| Article | Year |
|---|---|
A multi-centre randomised phase III trial of Dexamethasone vs Dexamethasone and diethylstilbestrol in castration-resistant prostate cancer: immediate vs deferred Diethylstilbestrol.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents, Hormonal; Carcinoma; Dexamethasone; Diethylstilbestrol; Disease Progression; Drug Administration Schedule; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Humans; Male; Orchiectomy; Prostatic Neoplasms; Treatment Failure; Treatment Outcome | 2011 |
Diethylstilbestrol in castration-resistant prostate cancer.
Topics: Aged; Diethylstilbestrol; Disease Progression; Estrogens, Non-Steroidal; Follow-Up Studies; Humans; Male; Orchiectomy; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Treatment Outcome | 2012 |
Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer.
Topics: Administration, Oral; Aged; Aged, 80 and over; Androgens; Anticoagulants; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Complementary Therapies; Cross-Over Studies; Diethylstilbestrol; Disease Progression; Drug Contamination; Drugs, Chinese Herbal; Estradiol Congeners; Ethinyl Estradiol; Humans; Male; Middle Aged; Prospective Studies; Prostatic Neoplasms; Reproducibility of Results; Treatment Outcome; Warfarin | 2004 |
American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer.
Topics: Androgens; Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; Cross-Over Studies; Diethylstilbestrol; Disease Progression; Drug Contamination; Drugs, Chinese Herbal; Follow-Up Studies; Humans; Male; Neoplasms, Hormone-Dependent; Phytotherapy; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Treatment Outcome | 2005 |
Clinical experience of hormone therapy to bone metastatic prostate cancer.
Topics: Adult; Aged; Bone Neoplasms; Diethylstilbestrol; Disease Progression; Dose-Response Relationship, Drug; Drug Therapy, Combination; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Male; Middle Aged; Neoplasm Staging; Prostatic Neoplasms; Survival Rate | 2006 |
Effect of adjuvant chemotherapy with or without anthracyclines on the activity and efficacy of first-line cyclophosphamide, epidoxorubicin, and fluorouracil in patients with metastatic breast cancer.
Topics: Adult; Aged; Analysis of Variance; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Diethylstilbestrol; Disease Progression; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged | 1996 |
Randomized trial of diethylstilbestrol vs. tamoxifen in postmenopausal women with metastatic breast cancer. An updated analysis.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Bone Neoplasms; Breast Neoplasms; Diethylstilbestrol; Disease Progression; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Metastasis; Postmenopause; Soft Tissue Neoplasms; Survival Analysis; Tamoxifen | 1999 |
Endocrine plus uracil/tegafur therapy for prostate cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Diethylstilbestrol; Disease Progression; Drug Therapy, Combination; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Prostatic Neoplasms; Tegafur; Treatment Outcome; Uracil | 1999 |
Phase II trial of bicalutamide in patients with advanced prostate cancer in whom conventional hormonal therapy failed: a Southwest Oncology Group study (SWOG 9235).
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Diethylstilbestrol; Disease Progression; Humans; Male; Middle Aged; Nitriles; Orchiectomy; Pain; Pain Measurement; Palliative Care; Prostate-Specific Antigen; Prostatic Neoplasms; Quality of Life; Tosyl Compounds; Treatment Outcome | 2001 |
15 other study(ies) available for diethylstilbestrol and Disease Exacerbation
| Article | Year |
|---|---|
Antitumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer.
Topics: Adult; Aged; Aged, 80 and over; Androgen Antagonists; Androstenes; Androstenols; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Diethylstilbestrol; Disease Progression; Docetaxel; Estrogens, Non-Steroidal; Humans; Male; Middle Aged; Orchiectomy; Prostate-Specific Antigen; Prostatic Neoplasms; Steroid 17-alpha-Hydroxylase; Taxoids; Treatment Outcome | 2013 |
Diethylstilbestrol for the treatment of patients with castration-resistant prostate cancer: retrospective analysis of a single institution experience.
Topics: Aged; Aged, 80 and over; Anticoagulants; Diethylstilbestrol; Disease Progression; Estrogens, Non-Steroidal; Gonadotropin-Releasing Hormone; Humans; Male; Middle Aged; Orchiectomy; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Pulmonary Embolism; Retrospective Studies; Treatment Outcome; Venous Thromboembolism | 2014 |
Diethylstilboestrol (1 mg) in the management of castration-resistant prostate cancer.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Diethylstilbestrol; Disease Progression; Estrogens, Non-Steroidal; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Retrospective Studies; Treatment Outcome | 2015 |
[Recent advances on precursor lesions of female reproductive tract].
Topics: Diethylstilbestrol; Disease Progression; Endocrine Disruptors; Female; Humans; Urologic Diseases | 2008 |
Playing the old piano: another tune for endocrine therapy?
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Line, Tumor; Clinical Trials as Topic; Diethylstilbestrol; Disease Progression; Drug Administration Schedule; Estrogen Receptor Modulators; Female; Humans; Male; Neoplasms, Hormone-Dependent; Ovariectomy; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Tamoxifen; Time Factors; Treatment Outcome | 2003 |
Re: the economic burden of metastatic and prostate specific antigen progression in patients with prostate cancer: findings from a retrospective analysis of health plan data.
Topics: Antineoplastic Agents, Hormonal; Diethylstilbestrol; Disease Progression; Humans; Male; Neoplasm Metastasis; Prostate-Specific Antigen; Prostatic Neoplasms; Retrospective Studies | 2004 |
Prior estrogen therapy as a predictor of response to subsequent estramustine-based chemotherapy in patients with androgen-independent prostate cancer.
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Diethylstilbestrol; Disease Progression; Drugs, Chinese Herbal; Estramustine; Humans; Male; Prostate-Specific Antigen; Prostatic Neoplasms | 2005 |
Early expression of the Helicase-Like Transcription Factor (HLTF/SMARCA3) in an experimental model of estrogen-induced renal carcinogenesis.
Topics: Animals; Base Sequence; Cricetinae; Diethylstilbestrol; Disease Progression; DNA Helicases; DNA-Binding Proteins; Estrogens; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Kidney; Kidney Neoplasms; Male; Mesocricetus; Mice; Mice, Nude; Molecular Sequence Data; Neoplasms, Experimental; Sequence Homology, Nucleic Acid; Transcription Factors; Transcriptional Activation; Transplantation, Heterologous; Tumor Cells, Cultured | 2006 |
Re: Olav Erich Yri, Trine Bjoro and Sophie D. Fossa. Failure to achieve castration levels in patients using leuprolide acetate in locally advanced prostate cancer. Eur Urol 2006;49:54-58.
Topics: Antineoplastic Agents, Hormonal; Diethylstilbestrol; Disease Progression; Humans; Leuprolide; Male; Orchiectomy; Prostatic Neoplasms; Treatment Failure | 2007 |
[Prognostic importance of prostate specific antigen in patients with hormonally treated stage D2 prostate carcinoma].
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents; Combined Modality Therapy; Diethylstilbestrol; Disease Progression; Humans; Male; Middle Aged; Neoplasm Staging; Prognosis; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radiotherapy | 1996 |
Experience with low-dose oestrogen in the treatment of advanced prostate cancer: a personal view.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Diethylstilbestrol; Disease Progression; Edema; Gynecomastia; Humans; Male; Middle Aged; Orchiectomy; Prostatic Neoplasms; Survival Analysis; Survival Rate; Testosterone | 1996 |
The importance of continued endocrine treatment during chemotherapy of hormone-refractory prostate cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Diethylstilbestrol; Disease Progression; Epirubicin; Fluorouracil; Goserelin; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms | 1997 |
The role of volume-weighted mean nuclear volume in predicting disease outcome in patients with prostate cancer treated with radical prostatectomy.
Topics: Antineoplastic Agents; Cell Nucleus; Diethylstilbestrol; Disease Progression; Gonadotropin-Releasing Hormone; Humans; Male; Multivariate Analysis; Neoadjuvant Therapy; Predictive Value of Tests; Prognosis; Prostatectomy; Prostatic Neoplasms; Retrospective Studies; Survivors; Treatment Outcome | 1999 |
Cost-effectiveness of androgen suppression therapies in advanced prostate cancer.
Topics: Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cost-Benefit Analysis; Diethylstilbestrol; Disease Progression; Gonadotropin-Releasing Hormone; Humans; Male; Markov Chains; Neoplasm Recurrence, Local; Orchiectomy; Prostate-Specific Antigen; Prostatic Neoplasms; Quality of Life; Quality-Adjusted Life Years; Survival Analysis; Time Factors; Treatment Outcome; United States | 2000 |
Low serum testosterone level predicts worse response to endocrine therapy in Japanese patients with metastatic prostate cancer.
Topics: Aged; Aged, 80 and over; Anilides; Antineoplastic Agents, Hormonal; Bone Neoplasms; Chlormadinone Acetate; Diethylstilbestrol; Disease Progression; Flutamide; Gonadotropin-Releasing Hormone; Humans; Japan; Male; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Predictive Value of Tests; Prostate-Specific Antigen; Prostatic Neoplasms; Statistics, Nonparametric; Testosterone; Tosyl Compounds | 2002 |